Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Abraham, MN

Joann Abraham, Coon Rapids, MN US

Patent application numberDescriptionPublished
20100030302METHOD FOR DISPLAYING TRENDED DATA RETRIEVED FROM A MEDICAL DEVICE - A system for displaying trended data retrieved from a medical device comprising a medical device which monitors and stores trended patient data, a data center, and an intermediate data relay device. The intermediate device receives stored trended patient data from the medical device and uploads the data to the data center. The data center merges the uploaded data with patient data obtained during previous data uploads. Clinicians can access the uploaded and merged patient using an interactive web page which allows the clinicians to seamlessly view the data.02-04-2010

John Patrick Abraham, Minneapolis, MN US

Patent application numberDescriptionPublished
20110313535UROLOGICAL REPAIR APPARATUS AND METHOD - A urological repair device includes a stent having a diameter that fits within a portion of a urological structure. The stent also has a length to bridge a distance between a first end of the urological structure and a second end of the urological structure. The stent includes at least one tapered end. The tapered end enables placement of the stent within the urological structure. A method of repairing a urological structure includes placing a first end of a substantially tubular urological structure over a first end of a tubular stent, and placing a second end of a substantially tubular urological structure over a second end of a stent, and attaching the first end of the substantially tubular urological structure, the second end of a substantially tubular urological structure, and the tubular stent to form a fluid passageway.12-22-2011

Roshini Sarah Abraham, Rochester, MN US

Patent application numberDescriptionPublished
20090062237EVALUATING IMMUNE COMPETENCE - This document relates to methods and materials involved in evaluating immune competence in a subject. For example, methods and materials for evaluating immune competence in a subject to BK virus (BKV) are provided. Also provided are isolated peptides, compositions, and methods useful for evaluating whether or not a subject is BKV immunocompetent. Also provided are methods for treating BK virus nephropathy in a subject that is BKV immune incompetent.03-05-2009

Tim Abraham, Minnetonka, MN US

Patent application numberDescriptionPublished
20110160472CHEMICAL METHODS FOR TREATING A METATHESIS FEEDSTOCK - Various methods are provided for metathesizing a feedstock. In one aspect, a method includes providing a feedstock comprising a natural oil, chemically treating the feedstock under conditions sufficient to diminish catalyst poisons in the feedstock, and, following the treating, combining a metathesis catalyst with the feedstock under conditions sufficient to metathesize the feedstock.06-30-2011

Timothy R. Abraham, Lino Lake, MN US

Patent application numberDescriptionPublished
20120035694GROUNDING OF A SHIELD WITHIN AN IMPLANTABLE MEDICAL LEAD - Grounding of a shield that is located in an implantable medical lead may be done in many ways. The shield may be grounded directly to tissue from the lead body at one or more points along the lead body. The pathway for grounding may be a direct current pathway or be capacitively coupled. The pathway for grounding may utilize an exposed or nearly exposed shield at one or more points along the lead body. A jacket forming the lead body may have an outer layer removed at these points to provide the RF pathway to ground. Alternatively, the jacket may be doped with conductive particles at these points. Metal conductors such as ring electrodes and/or lead anchors may be attached to the lead at one or more points to provide the RF pathway to ground.02-09-2012

Timothy R. Abraham, Lino Lakes, MN US

Patent application numberDescriptionPublished
20100137945AUTOMATED VERIFICATION OF MRI COMPATIBILITY OF ACTIVE IMPLANTABLE MEDICAL DEVICE - A system may include a processor configured to automatically obtain magnetic resonance imaging compatibility information relating to compatibility of an active implantable medical device implantable in a patient with an MRI modality from at least two information sources. The processor may also be configured to automatically determine compatibility of the active implantable medical device with the magnetic resonance imaging modality based on the magnetic resonance imaging compatibility information.06-03-2010
20100137946PATIENT-CENTRIC DATA COLLECTION FOR AUTOMATED MRI COMPATIBILITY VERIFICATION - A system may include a patient information terminal that receives magnetic resonance imaging compatibility information from a patient and a processor that automatically determines compatibility of an active implantable medical device with an magnetic resonance imaging modality based on the magnetic resonance imaging compatibility information. The magnetic resonance imaging compatibility information includes information relating to compatibility of the active implantable medical device implantable in the patient and the magnetic resonance imaging modality.06-03-2010
20100137947PATIENT PROGRAMMER WITH AUTOMATED MRI COMPATIBILITY VERIFICATION FOR ACTIVE IMPLANTABLE MEDICAL DEVICE - A system may include an active implantable medical device implantable in a body of a patient and a patient programmer for the AIMD. The patient programmer may be configured to obtain magnetic resonance imaging (MRI) compatibility information relating to compatibility of the AIMD with an MRI modality.06-03-2010
20120035616STEERING AN IMPLANTABLE MEDICAL LEAD VIA A ROTATIONAL COUPLING TO A STYLET - An implantable medical lead has a torsional stiffness and is rotationally coupled to a stylet. Applying rotation directly to the lead in turn causes rotation of the stylet. Where the stylet has a bent tip for purposes of steering the lead, the rotation applied to the lead rotates the bent tip so that the lead can be steered by rotating the lead rather than rotating a hub of the stylet. The rotational coupling may be achieved through one or more features provided for the lead and/or the stylet, such as a feature within a lumen of the lead that mates to a feature along the stylet or a feature of the stylet hub that engages the proximal end of the lead. The torsional stiffness of the lead may be provided by adding a feature within the lead body, such as a braided metal wire or an overlapping foil.02-09-2012
20120035695GROUNDING OF A SHIELD WITHIN AN IMPLANTABLE MEDICAL LEAD - Grounding of a shield that is located in an implantable medical lead may be done in many ways. The ground pathway may couple to the shield at a point that is outside of a header of an implantable medical device to which the implantable medical lead is attached. The ground pathway may couple to the shield at a point that is within the header of the implantable medical device. The ground pathway may terminate at the metal can of the implantable medical device. As another option, the ground pathway may terminate at a ground plate that is mounted to the header. The ground pathway may be direct current coupled from the shield to the can or ground plate. Alternatively, the ground pathway may include one or more capacitive couplings that provide a pathway for induced radio frequency current.02-09-2012
20120035696TERMINATION OF A SHIELD WITHIN AN IMPLANTABLE MEDICAL LEAD - A shield located within an implantable medical lead may be terminated in various ways. The shield may be terminated by butt, scarf, lap, or other joints between insulation layers surrounding the lead and an insulation extension. For lap joints, a portion of an outer insulation layer may be removed and a replacement outer insulation layer is positioned in place of the removed outer insulation layer, where the replacement layer extends beyond an inner insulation layer and the shield. The replacement layer may also lap onto a portion of the insulation extension. Barbs may be located between the replacement layer and the inner insulation layer or the insulation extension. The shield wires have ends at the termination point that may be folded over individually or may be capped with a ring located within one of the insulation layers of the jacket.02-09-2012

Timothy W. Abraham, Wayzata, MN US

Patent application numberDescriptionPublished
20090117625Polypeptides and Biosynthetic Pathways for the Production of Monatin and Its Precursors - Methods and compositions that can be used to make monatin from glucose, tryptophan, indole-3-lactic acid, indole-3-pyruvate, and 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid, are provided. Methods are also disclosed for producing the indole-3-pyruvate and 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid intermediates. Compositions provided include nucleic acid molecules, polypeptides, chemical structures, and cells. Methods include in vitro and in vivo processes, and the in vitro methods include chemical reactions.05-07-2009

Timothy Walter Abraham, Minnetonka, MN US

Patent application numberDescriptionPublished
20090287007PARTIALLY-HYDROGENATED, FULLY-EPOXIDIZED VEGETABLE OIL DERIVATIVE - Disclosed is a method for making a partially hydrogenated, fully epoxidized vegetable oil derivative. The method includes fully epoxidizing a partially hydrogenated vegetable oil having an iodine value of 70 to 100 g I11-19-2009
20100048754VISCOELASTIC POLYURETHANE FOAMS COMPRISING OLIGOMERIC NATURAL OIL POLYOLS - Described are viscoelastic polyurethane foams that comprise an oligomeric natural oil polyol and a petroleum-derived polyol. The viscoelastic foams are formed by reacting a polyisocyanate with an active-hydrogen composition that comprises the oligomeric natural oil polyol and petroleum-derived polyol.02-25-2010
20100087561VISCOELASTIC POLYURETHANE FOAMS COMPRISING AMIDATED OR TRANSESTERIFIED OLIGOMERIC NATURAL OIL POLYOLS - Described are viscoelastic polyurethane foams that comprise the reaction product of a polyisocyanate and an active-hydrogen composition comprising an amidated or transesterified oligomeric natural oil polyol.04-08-2010
20100240860NATURAL OIL-DERIVED POLYESTER POLYOLS AND POLYURETHANES MADE THEREFROM - A polyester polyol made from natural oil feedstocks is disclosed. Methods for making the polyol are also disclosed. The method comprises reacting monohydroxylated fatty acid/alkyl esters with a multifunctional ester-reactive initiator compound to form the polyester polyol. In one embodiment, the monohydroxylated fatty acid/alkyl esters are made by hydroxylating fatty acid/alkyl esters having greater than about ninety-five percent by weight monounsaturation.09-23-2010
20100267925NATURAL OIL-DERIVED POLYESTER POLYOLS AND POLYURETHANES MADE THEREFROM - A polyester polyol made from natural oil feedstocks is disclosed. Methods for making the polyol are also disclosed. The method comprises reacting hydroxylated fatty acid/alkyl esters with a multifunctional ester-reactive initiator compound to form the polyester polyol. In one embodiment, the hydroxylated fatty acid/alkyl esters are made by hydroxylating fatty acid/alkyl esters having up to ninety-five percent by weight monounsaturation.10-21-2010